Hims & Hers Health trading volume on March 3 was $434 million, ranking 333rd among U.S. stocks that day.

robot
Abstract generation in progress

On March 3, 2026, Hims & Hers Health (HIMS), a healthcare and wellness services company, had a trading volume of $434 million, ranking 333rd among U.S. stocks that day. Its trading volume decreased by 16.28% from the previous day, with a total of 27.3872 million shares traded.

Hims & Hers Health (HIMS) closed at $15.82 on March 3, 2026, down 4.00%. The stock has increased by 2.33% over the past five trading days, up 8.95% for the entire month of March, and has fallen 51.28% since the beginning of the year. Over the past 52 weeks, it has declined by 61.11%.

If the company’s listing duration is less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to listings less than 1 month or fewer than 5 trading days).

Hims & Hers Health (HIMS) Trading Volume / USD Change from Previous Day Shares Traded
March 3, 2026 $434 million -16.28% 27.3872 million
March 2, 2026 $518 million +49.44% 32.8362 million
February 27, 2026 $347 million -24.59% 23.4846 million
February 26, 2026 $460 million -24.87% 29.4312 million
February 25, 2026 $612 million -36.28% 38.3178 million

Hims & Hers Health, Inc. was founded on December 30, 2013, as a Delaware corporation. Their mission is to make healthcare affordable and accessible for everyone. They design and build cloud-based, digital-native technology with a consumer-centric approach. Their proprietary website, telemedicine platform, electronic health record system, pharmacy integration, and mobile accessibility combine to provide consumers with a seamless, user-friendly, mobile-first experience.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments